[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Sickle Cell Disease Drug Market Research Report 2018

March 2018 | 107 pages | ID: CA391D4F0CDEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Sickle Cell Disease Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Sickle Cell Disease Drug development status and future trend in China, focuses on top players in China, also splits Sickle Cell Disease Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Acceleron Pharma Inc
  • Addmedica SAS
  • Angiocrine Bioscience Inc
  • Annexin Pharmaceuticals AB
  • ArQule Inc
  • Bio Products Laboratory Ltd
  • Bioverativ Inc
  • bluebird bio Inc
  • Bristol-Myers Squibb Co
  • Calimmune Inc
  • CRISPR Therapeutics
  • CSL Ltd
  • Daiichi Sankyo Co Ltd
  • Editas Medicine Inc
  • Errant Gene Therapeutics LLC
  • Gamida Cell Ltd
  • Genethon SA
  • Gilead Sciences Inc
  • Global Blood Therapeutics Inc
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
  • ARQ-092
  • BIVV-003
  • CAL-H
  • CTX-001
  • DRX-194
  • Others
On the basis of the end users/application, this report covers
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
China Sickle Cell Disease Drug Market Research Report 2018

1 SICKLE CELL DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Sickle Cell Disease Drug
1.2 Classification of Sickle Cell Disease Drug by Product Category
  1.2.1 China Sickle Cell Disease Drug Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 China Sickle Cell Disease Drug Sales (K Pcs) Market Share by Type in 2017
  1.2.3 ARQ-092
  1.2.4 BIVV-003
  1.2.5 CAL-H
  1.2.6 CTX-001
  1.2.7 DRX-194
  1.2.8 Others
1.3 China Sickle Cell Disease Drug Market by Application/End Users
  1.3.1 China Sickle Cell Disease Drug Sales (K Pcs) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 China Sickle Cell Disease Drug Market by Region
  1.4.1 China Sickle Cell Disease Drug Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Sickle Cell Disease Drug Status and Prospect (2013-2025)
  1.4.3 East China Sickle Cell Disease Drug Status and Prospect (2013-2025)
  1.4.4 Southwest China Sickle Cell Disease Drug Status and Prospect (2013-2025)
  1.4.5 Northeast China Sickle Cell Disease Drug Status and Prospect (2013-2025)
  1.4.6 North China Sickle Cell Disease Drug Status and Prospect (2013-2025)
  1.4.7 Central China Sickle Cell Disease Drug Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Sickle Cell Disease Drug (2013-2025)
  1.5.1 China Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.5.2 China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA SICKLE CELL DISEASE DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Sickle Cell Disease Drug Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Sickle Cell Disease Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Sickle Cell Disease Drug Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 China Sickle Cell Disease Drug Market Competitive Situation and Trends
  2.4.1 China Sickle Cell Disease Drug Market Concentration Rate
  2.4.2 China Sickle Cell Disease Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA SICKLE CELL DISEASE DRUG SALES AND REVENUE BY REGION (2013-2018)

3.1 China Sickle Cell Disease Drug Sales (K Pcs) and Market Share by Region (2013-2018)
3.2 China Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Sickle Cell Disease Drug Price (USD/Pcs) by Regions (2013-2018)

4 CHINA SICKLE CELL DISEASE DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Sickle Cell Disease Drug Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
4.2 China Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Sickle Cell Disease Drug Price (USD/Pcs) by Type (2013-2018)
4.4 China Sickle Cell Disease Drug Sales Growth Rate (%) by Type (2013-2018)

5 CHINA SICKLE CELL DISEASE DRUG SALES BY APPLICATION (2013-2018)

5.1 China Sickle Cell Disease Drug Sales (K Pcs) and Market Share by Application (2013-2018)
5.2 China Sickle Cell Disease Drug Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA SICKLE CELL DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Acceleron Pharma Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Addmedica SAS
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Angiocrine Bioscience Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Annexin Pharmaceuticals AB
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 ArQule Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Bio Products Laboratory Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Bioverativ Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 bluebird bio Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Bristol-Myers Squibb Co
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Calimmune Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Sickle Cell Disease Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview
6.11 CRISPR Therapeutics
6.12 CSL Ltd
6.13 Daiichi Sankyo Co Ltd
6.14 Editas Medicine Inc
6.15 Errant Gene Therapeutics LLC
6.16 Gamida Cell Ltd
6.17 Genethon SA
6.18 Gilead Sciences Inc
6.19 Global Blood Therapeutics Inc

7 SICKLE CELL DISEASE DRUG MANUFACTURING COST ANALYSIS

7.1 Sickle Cell Disease Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sickle Cell Disease Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sickle Cell Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sickle Cell Disease Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA SICKLE CELL DISEASE DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
11.2 China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Type (2018-2025)
11.3 China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Application (2018-2025)
11.4 China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Sickle Cell Disease Drug Sales (K Pcs) by Application (2013-2025)
Figure Product Picture of Sickle Cell Disease Drug
Table China Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Sickle Cell Disease Drug Sales Volume Market Share by Types in 2017
Figure ARQ-092 Product Picture
Figure BIVV-003 Product Picture
Figure CAL-H Product Picture
Figure CTX-001 Product Picture
Figure DRX-194 Product Picture
Figure Others Product Picture
Figure China Sickle Cell Disease Drug Sales (K Pcs) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Sickle Cell Disease Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Sickle Cell Disease Drug Sales of Key Players/Manufacturers (2013-2018)
Table China Sickle Cell Disease Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Sickle Cell Disease Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Sickle Cell Disease Drug Sales Share (%) by Players/Manufacturers
Table China Sickle Cell Disease Drug Revenue by Players/Manufacturers (2013-2018)
Table China Sickle Cell Disease Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Sickle Cell Disease Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Sickle Cell Disease Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Sickle Cell Disease Drug Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Sickle Cell Disease Drug Average Price of Key Players/Manufacturers in 2017
Figure China Sickle Cell Disease Drug Market Share of Top 3 Players/Manufacturers
Figure China Sickle Cell Disease Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Sickle Cell Disease Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Sickle Cell Disease Drug Product Category
Table China Sickle Cell Disease Drug Sales (K Pcs) by Regions (2013-2018)
Table China Sickle Cell Disease Drug Sales Share (%) by Regions (2013-2018)
Figure China Sickle Cell Disease Drug Sales Share (%) by Regions (2013-2018)
Figure China Sickle Cell Disease Drug Sales Market Share (%) by Regions in 2017
Table China Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Sickle Cell Disease Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Sickle Cell Disease Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Sickle Cell Disease Drug Revenue Market Share (%) by Regions in 2017
Table China Sickle Cell Disease Drug Price (USD/Pcs) by Regions (2013-2018)
Table China Sickle Cell Disease Drug Sales (K Pcs) by Type (2013-2018)
Table China Sickle Cell Disease Drug Sales Share (%) by Type (2013-2018)
Figure China Sickle Cell Disease Drug Sales Share (%) by Type (2013-2018)
Figure China Sickle Cell Disease Drug Sales Market Share (%) by Type in 2017
Table China Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Sickle Cell Disease Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Sickle Cell Disease Drug by Type (2013-2018)
Figure Revenue Market Share of Sickle Cell Disease Drug by Type in 2017
Table China Sickle Cell Disease Drug Price (USD/Pcs) by Types (2013-2018)
Figure China Sickle Cell Disease Drug Sales Growth Rate (%) by Type (2013-2018)
Table China Sickle Cell Disease Drug Sales (K Pcs) by Applications (2013-2018)
Table China Sickle Cell Disease Drug Sales Market Share (%) by Applications (2013-2018)
Figure China Sickle Cell Disease Drug Sales Market Share (%) by Application (2013-2018)
Figure China Sickle Cell Disease Drug Sales Market Share (%) by Application in 2017
Table China Sickle Cell Disease Drug Sales Growth Rate (%) by Application (2013-2018)
Figure China Sickle Cell Disease Drug Sales Growth Rate (%) by Application (2013-2018)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Basic Information List
Table Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Addmedica SAS Sickle Cell Disease Drug Basic Information List
Table Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Basic Information List
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Basic Information List
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table ArQule Inc Sickle Cell Disease Drug Basic Information List
Table ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Basic Information List
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Bioverativ Inc Sickle Cell Disease Drug Basic Information List
Table Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table bluebird bio Inc Sickle Cell Disease Drug Basic Information List
Table bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Basic Information List
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table Calimmune Inc Sickle Cell Disease Drug Basic Information List
Table Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Sales Market Share (%) in China (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Revenue Market Share (%) in China (2013-2018)
Table CRISPR Therapeutics Sickle Cell Disease Drug Basic Information List
Table CSL Ltd Sickle Cell Disease Drug Basic Information List
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Basic Information List
Table Editas Medicine Inc Sickle Cell Disease Drug Basic Information List
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Basic Information List
Table Gamida Cell Ltd Sickle Cell Disease Drug Basic Information List
Table Genethon SA Sickle Cell Disease Drug Basic Information List
Table Gilead Sciences Inc Sickle Cell Disease Drug Basic Information List
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sickle Cell Disease Drug
Figure Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure Sickle Cell Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Sickle Cell Disease Drug Major Players/Manufacturers in 2017
Table Major Buyers of Sickle Cell Disease Drug
Table Distributors/Traders List
Figure China Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Sickle Cell Disease Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Sickle Cell Disease Drug Sales Volume Market Share Forecast by Type in 2025
Table China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure China Sickle Cell Disease Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Sickle Cell Disease Drug Sales Volume Market Share Forecast by Application in 2025
Table China Sickle Cell Disease Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Table China Sickle Cell Disease Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Sickle Cell Disease Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Sickle Cell Disease Drug Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories